OMNI Health, Inc.
Other OTCTotal Valuation
OMNI Health, Inc. carries a market capitalization of 29,291.00, placing it among publicly traded companies globally. Its enterprise value stands at 42.32M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 29,291.00 |
| Enterprise Value | 42.32M |
Share Statistics
OMNI Health, Inc. currently has 975.83M shares outstanding.
| Shares Outstanding | 975.83M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
OMNI Health, Inc. trades at a trailing price-to-earnings ratio of 86.97. The price-to-sales ratio is 12.30, and the price-to-book ratio stands at 94.33.
| PE Ratio | 86.97 |
| PS Ratio | 12.30 |
| PB Ratio | 94.33 |
| P/TBV Ratio | 12.85 |
| P/FCF Ratio | -251.64 |
| P/OCF Ratio | -85.93 |
Enterprise Valuation
| EV / Sales | 12.57 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 38.61 |
Financial Position
OMNI Health, Inc. maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.07 |
| Quick Ratio | 0.83 |
| Debt / Equity | 28.71 |
| Debt / EBITDA | -2.05 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 18.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 16.25 |
Stock Price Statistics
OMNI Health, Inc.'s stock has gained approximately 200% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 200% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, OMNI Health, Inc. generated 3.37M in revenue and converted that into 476,105.00 in net income, yielding earnings per share of 0.00. EBITDA reached -451,079.00, while operating income came in at -461,516.00.
| Revenue | 3.37M |
| Gross Profit | 901,196.00 |
| Operating Income | -461,516.00 |
| Pretax Income | -605,068.00 |
| Net Income | 476,105.00 |
| EBITDA | -451,079.00 |
| EBIT | -461,516.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
OMNI Health, Inc. holds 7,649.00 in cash and equivalents against 924,985.00 in total debt, resulting in a net debt position of 917,336.00. Total book value stands at 438,966.00, with working capital of 86,473.00 providing operational flexibility.
| Cash & Cash Equivalents | 7,649.00 |
| Total Debt | 924,985.00 |
| Net Debt | 917,336.00 |
| Equity (Book Value) | 438,966.00 |
| Book Value Per Share | 0.00 |
| Working Capital | 86,473.00 |
Cash Flow
OMNI Health, Inc. produced -481,843.00 in operating cash flow over the past twelve months. After subtracting -317,292.00 in capital expenditures, free cash flow totaled -799,135.00 - equivalent to 0.00 per share.
| Operating Cash Flow | -481,843.00 |
| Capital Expenditures | -317,292.00 |
| Free Cash Flow | -799,135.00 |
| FCF Per Share | 0.00 |
Margins
OMNI Health, Inc. operates with a gross margin of 26.77, reflecting its pricing power and cost economics. The operating margin of -13.71 and net profit margin of 14.14 provide insight into operational efficiency.
| Gross Margin | 26.77 |
| Operating Margin | -13.71 |
| Pretax Margin | -17.97 |
| Profit Margin | 14.14 |
| EBITDA Margin | -13.40 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.69 |
| FCF Yield | -0.40 |
Scores
OMNI Health, Inc. posts an Altman Z-Score of 14.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.33 |